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Summary
Age-related defects in fibroblast differentiation were previously
shown to be associated with impaired hyaluronan synthase 2
(HAS2) andepidermalgrowth factor receptor (EGFR) function,with
both required for normal fibroblast functionality. In fibroblasts,
transforming growth factor-beta 1 (TGF-b1)-dependent pheno-
typic activation uses two distinct but co-operating pathways that
involveTGF-b receptor (TGF-bR)/Smad2activationandHA-mediated
CD44-EGFR co-localization and signalling through extracellular
signal-regulated kinase 1/2 (ERK1/2). TheHA-mediated CD44-EGFR
pathway was found to be compromised with in vitro aging,
through loss of EGFR expression and a reducedmovement of CD44
throughout the cellular membrane. Here, we also investigate the
involvement of microRNAs (miRNAs) in age-related loss of differ-
entiation, through investigation of miRNA-7 (miR-7) regulation of
the HA-mediated EGFR-signalling pathway. The transcription of
miR-7 was found to be upregulated in aged cells. In young cells,
age-related loss of differentiation could be mimicked through
transfection of pre-miR-7, and in aged cells, could be reversed
through transfection of locked nucleic acids (LNA) targetingmiR-7.
Additionally, miR-7 was found to be involved in the regulation of
CD44 membrane motility, which was downregulated in instances
ofmiR-7 upregulation, andpartially restorable througheithermiR-
7 inhibition or HAS2 overexpression. The altered dynamics of CD44
in the cell membrane demonstrated a further action of miR-7 in
regulating the HA-dependent CD44/EGFR pathway. We explain
this novel mechanism of age-associated functional consequence
due to miR-7 upregulation and demonstrate that it is reversible;
highlighting miR-7 as a potential target for restoring the healing
capabilities in chronic wounds in the elderly.
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Introduction
Wound healing, regardless of the aetiology of the wound, involves an
overlapping sequence of events that culminate in remodelling of the
extracellular matrix and restoration of tissue integrity. Fibroblasts are
central to this and when activated by transforming growth factor-b1
(TGF-b1), they undergo phenotypic transition into a-smooth muscle actin
(a-SMA) positive, contractile myofibroblasts (Gabbiani, 2003). These
myofibroblasts are responsible for wound closure and the formation of
the collagen-rich scar. It has been demonstrated previously that
fibroblasts isolated from aging skin have impaired migration, impaired
proliferative response and defects in matrix generation compared to
those from young skin (Ashcroft et al., 1995; Shiraha et al., 2000).
Furthermore, we have shown that aging cells are resistant to TGF-b1-
triggered fibroblast to myofibroblast differentiation, despite the normal
activation of the TGF-b1 intracellular signalling pathways (Simpson et al.,
2009, 2010).
We have previously demonstrated that hyaluronan (HA), synthesized
by HA synthase (HAS) 2, is a key factor in the regulation of fibroblast
differentiation (Meran et al., 2007; Webber et al., 2009). In addition, HA
is involved in mediating cellular responses to TGF-b1. For example, our
previous studies in epithelial and fibroblast cells have demonstrated that
HA modulates TGF-b1 signalling after interaction with its receptor,
CD44, promoting CD44-epidermal growth factor receptor (EGFR)
co-localization and downstream signalling (Ito et al., 2004a,b; Simpson
et al., 2010). Age-related failure of TGF-b1- induced differentiation to
the myofibroblast phenotype is associated with the inability to induce
HAS2, a decrease in HA synthesis, and a lack of pericellular coat
formation. HA synthesis and coat assembly could be restored by forced
expression of HAS2 followed by TGF-b1 stimulation (Simpson et al.,
2009). This did not, however, restore the myofibroblast phenotype, and
studies, including our own, have demonstrated that the loss of EGFR
expression and its responsiveness in aged cells is central to age-related
resistance to differentiation (Shiraha et al., 2000; Simpson et al., 2010).
MicroRNAs (miRNAs) are small, single-stranded and looped 18–23
nucleotide RNA molecules that function as regulators of gene expression
by binding and actively inhibiting the expression ofmRNA tomoderate cell
function such as proliferation and differentiation. The microRNA, miR-7
has been shown to antagonize EGFR expression (Kefas et al., 2008), to be
involved in EGFR-related cancer progression (Webster et al., 2009; Chou
et al., 2010), and to regulate EGFR-mediated development (Li & Carthew,
2005). However, whether or notmiR-7 is implicated in age-associated loss
of EGFR and therefore fibroblast resistance to differentiation has yet to be
investigated. Our hypothesis is that age-related miR-7 upregulation may
be central to the loss of the HA-dependent EGFR signalling pathway.
Herein, we show that miR-7 affects the cellular expression and function-
ality of EGFR implicating a role in the cellular resistance to differentiation
and detail the functional consequences arising frommiR-7 upregulation in
young cells. In addition, we demonstrate that inhibition of miR-7 can
rescue the differentiation response in in vitro aged fibroblasts. Further-
more, we describe a novel mechanism in which miR-7 regulates the
HA-mediated CD44/EGFR signalling pathway through loss of CD44
cellular membrane motility. We also show that miR-7 inhibition can
restore CD44movement in a similar manner to HAS2 overexpression, thus
highlighting how miR-7 can indirectly regulate HA and CD44 and the
subsequent loss of differentiation in response to TGF-b1 stimulation.
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Results
Aging fibroblasts have decreased expression of EGFR mRNA
and protein but maintain promoter activity
Previous studies, including our own (Shiraha et al., 2000; Simpson et al.,
2009, 2010) have demonstrated a loss of EGFR that correlates with
increasing fibroblast population doubling. However, it is not clear what
mechanism dictates this loss of expression. To determine the extent of
EGFR loss in our cell system, we analysed EGFR mRNA, total protein, cell
surface expression and constitutive EGFR promoter activity in young and
aged fibroblasts. EGFR mRNA analysed by quantitative PCR (QPCR) was
found to be significantly down-regulated in aged fibroblasts (Fig. 1A).
This was reflected in age-associated loss of both EGFR total protein, as
determined by Western blot (Fig. 1B), and cell surface expression, as
determined by flow cytometry (Fig. 1C). Interestingly, when the activity
of the EGFR promoter using a luciferase reporter construct was tested,
no observable differences in luminescent intensity were observed
between young and aged cells (Fig. 1D), suggesting that the downre-
gulation of EGFR mRNA and protein were not necessarily a result of
reduced levels of transcription factors binding to the EGFR promoter,
and thus, the aged-associated loss of EGFR could be a consequence of
post-transcriptional activity.
Cellular membrane mobility of CD44 is lost in aged fibroblasts
The loss of EGFR expression in aged fibroblasts has been reported to
impact on a reduced differentiation potential through a loss of the
interaction between CD44 and EGFR, an important step in driving
fibroblast to myofibroblast transformation (Simpson et al., 2010; Meran
(A)
(C) (D)
(B)
Fig. 1 EGFR expression is downregulated in aging of fibroblasts. (A) Young and aged fibroblasts were grown to confluent monolayers and were growth arrested for 48 h.
Cells were then incubated in serum-free medium alone or in medium containing 10 ng/mL TGF-b1 for 72 h. The expression of EGFR mRNA was examined by QPCR and
results are shown as the mean  SEM of three individual experiments. (B) Western blot analysis of total EGFR protein in young and aged fibroblasts. GAPDH was used as a
loading control. Representative blot is shown and densitometry graph shown is the mean  SEM of three individual experiments. (C) Flow cytometry analysis of cell surface
expression of EGFR in young (green) and aged (red) fibroblasts. Unlabelled cells (black) were used as intensity controls. Bar graph of relative intensity shown is the
mean  SEM of three individual experiments. (D) Young or aged fibroblasts were grown to 70% confluence and transiently transfected with either an empty pGL3b vector
or pGL3b-EGFR. Luminescence was measured averaged. Cells were co-transfected with Renilla to measure efficiency and to normalize data. Graph shown is the
mean  SEM of three individual experiments. N/S = no significance, **P ≤ 0.01. EGFR, epidermal growth factor receptor.
miR-7 inhibition rescues differentiation, A. C. Midgley et al.236
ª 2013 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
et al., 2011; Midgley et al., 2013). We previously highlighted the
importance of CD44 membrane motility in contribution to EGFR
interaction (Midgley et al., 2013). Here, we examined whether the
receptor behaviour of EGFR altered in aged cells, and whether the ability
of CD44 to move within the cell membrane was also affected using
fluorescence recovery after photobleaching (FRAP). Representative FRAP
images are shown for young fibroblast EGFR and CD44 (Fig. 2A). EGFR
was found to remain within static domains across the membrane
regardless of cellular age (Fig. 2B,C). In contrast, while CD44 had the
potential to move throughout the membrane in young fibroblasts
(Fig. 2D), this was lost in aged fibroblasts (Fig. 2E). These data suggest
that CD44 mobility could be another contributor to the age-associated
loss of differentiation and could explain why previously overexpressed
EGFR alone (Simpson et al., 2010) was not sufficient to fully restore aged
fibroblast differentiation to myofibroblasts.
MicroRNA-7 targets the 3′UTR of EGFR and is upregulated in
aged fibroblasts
MicroRNA-7 (miR-7) has been reported to target and prevent EGFR
production in many instances such as in cancers and during development
(Li & Carthew, 2005; Webster et al., 2009; Chou et al., 2010). In silico
(A)
(B) (C)
(D) (E)
Fig. 2 CD44 cellular membrane mobility is reduced in aging fibroblasts. (A) Sample time-lapse series of fluorescent recovery after photobleaching (FRAP) experiments.
Original magnification 9630. Young or aged fibroblasts were grown to 70% confluent monolayers on 22 mm diameter glass coverslips in 35 mm six-well tissue culture
plates. Cells were growth arrested in serum-free medium for 48 h. FRAP was performed at 37 °C by photobleaching an approximately 10 lm area of the cell membrane
(indicated by white boxes). The recovery of fluorescence into this area (indicated by white arrows) was quantified and expressed as a fraction of the fluorescence intensity (FI)
of a second region of membrane outside of the photobleached area (FI Ratio). Complete quantified time-courses, average diffusion constants (D) and mobile fractions (MF)
are shown for: (B) EGFR in young fibroblasts; (C) EGFR in aged fibroblasts; (D) CD44 in young fibroblasts and E. CD44 in aged fibroblasts. All results shown are mean  SEM
of five independent experiments. EGFR, epidermal growth factor receptor.
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analysis revealed one highly conserved and two poorly conserved seed
sites for miR-7 within the 3′. UTR of EGFR mRNA (Fig. 3A). In order to
determine whether or not miR-7 was upregulated in aged fibroblasts,
miR-RT followed by QPCR was used. Results showed that miR-7 was
found to have a higher expression in aged fibroblasts and in cells
stimulated with TGF-b1 when compared to young untreated control cells
(Fig. 3B). These data coincide with the downregulation of EGFR mRNA
and protein in aged fibroblasts as seen in Fig. 1.
Overexpression of miR-7 in young fibroblasts causes a loss of
EGFR similar to that in aged fibroblasts
Analysis of the effects of overexpression of miR-7 was examined through
transfection of pre-miR-7 into young fibroblasts. The relative expression
of miR-7 was determined by QPCR and in cells transfected with pre-miR-
7 the results showed a significantly large increase in the levels of miR-7
present (Fig. 4A). EGFR mRNA was found to be significantly downreg-
ulated in cells transfected with pre-miR-7 (Fig. 4B), while a-SMA
(Fig. 4C) and HAS2 (Fig. 4D) mRNA failed to be induced by TGF-b1
treatment. The extra-domain A containing variants of fibronectin (EDA-
FN) are associated with differentiation, and its expression is necessary for
successful myofibroblast generation (Kohan et al., 2010); transfection of
pre-miR-7 also prevented the upregulation of EDA-FN mRNA by TGF-b1
(Fig. 4E). These data indicated that miR-7 upregulation had the potential
to negatively regulate the essential components involved in fibroblast to
myofibroblast differentiation, including those previously described
(Simpson et al., 2009, 2010; Webber et al., 2009; Meran et al.,
2011). Similarly, both total EGFR protein (Fig. 4F) and EGFR cell surface
expression (Fig. 4G) were found to be approximately halved in the
presence of pre-miR-7 transfections. To determine whether or not pre-
miR-7 transfected cells were still able to differentiate following TGF-b1
stimulation, we used immunocytochemistry for a-SMA. a-SMA fibril
formation was lost in cells transfected with pre-miR-7, indicating a
prevention of differentiation (Fig 4H).
Inhibition of miR-7 in aged fibroblasts rescues the TGF-b1-
stimulated differentiation response
To test our hypothesis that miR-7 was effectively inhibiting the
differentiation response in aged fibroblasts, we transfected miR-7 locked
nucleic acids (LNA) to bind and inhibit free miR-7 within our cells. As
predicted, EGFR mRNA was upregulated in miR-7 LNA transfected cells
compared with negative control LNA transfected cells and did not fall
when the cells were treated with TGF-b1 (Fig. 5A). The contributors to
myofibroblast differentiation; a-SMA (Fig. 5B), HAS2 (Fig. 5C), and EDA-
FN (Fig. 5D) mRNA, were significantly upregulated following TGF-b1
stimulation. Total EGFR protein (Fig. 5E) and cell surface expression
(Fig. 5F) were increased in aged fibroblasts transfected with miR-7 LNA.
Determination of cellular differentiation was tested, and in cells that had
been transfected with miR-7 LNA, there was fluorescence for a-SMA
intracellular fibrils (Fig. 5G), indicating that the aged fibroblasts had the
ability to differentiate restored if miR-7 was prevented from acting.
These data demonstrate the effectiveness of targeting miR-7 in restoring
the differentiation response in aged fibroblasts, revealing a potentially
valuable mechanism to target in chronic nonhealing wounds in the
elderly.
Inhibition of miR-7 can restore CD44 membrane motility
through a HAS2-dependent mechanism
It has been suggested that the loss of CD44 motility in the membrane of
aged fibroblasts could prevent the HA-dependent CD44/EGFR interac-
tion necessary for differentiation (Simpson et al., 2010; Meran &
Steadman, 2011; Meran et al., 2011). Observations from the results
presented in Fig. 2 showed a loss of CD44 motility in aged fibroblasts;
we therefore examined whether overexpression or inhibition of miR-7
would affect CD44 membrane movement. Young fibroblasts were
transfected with either a scrambled pre-miR sequence (Fig. 6A) or with
pre-miR-7 (Fig. 6B). Interestingly, in cells transfected with pre-miR-7 the
potential for CD44 movement throughout the membrane, as highlighted
by the diffusion constant (D) and mobile fraction (MF), dropped
significantly (both P < 0.01) when compared to the scrambled control
transfection. These data are indicative of miR-7 having an indirect action
on CD44 receptor behaviour. We then examined the inhibition of miR-7
in aged fibroblasts using negative control LNA (Fig. 6C) and miR-7 LNA
(Fig. 6D). When aged cells were transfected with miR-7 LNA, the
diffusion constant was increased when compared to negative control
LNA transfected cells (P ≤ 0.05). The MF of CD44, although significantly
increased (P ≤ 0.05), was not restored to the levels shown in younger
fibroblasts (P ≤ 0.01 vs. Fig. 2D). We hypothesized that the reason for
the restoration seen in miR-7 inhibitory experiments was due to an
upregulated the presence of HAS2-produced HA. To test this hypothesis,
we transfected aged fibroblasts with an empty vector (Fig. 6E) or with a
HAS2 overexpression vector (Fig. 6F). In cells overexpressing HAS2, there
was an observable restoration in CD44 diffusion compared with the
(A)
(B)
Fig. 3 MicroRNA-7 targets 3′UTR of EGFR mRNA and is upregulated in aging
fibroblasts. (A) Highly conserved and poorly conserved microRNA-7 (miR-7) seed
sites on the 3′UTR of EGFR mRNA as determined by in silico analysis with
TargetScan v6.2 (Whitehead Institute, Cambridge, MA, USA). (B) Young and aged
fibroblasts were grown to confluent monolayers and were growth arrested for
48 h. Cells were then incubated in serum-free medium alone or in medium
containing 10 ng/mL TGF-b1 for 72 h. The expression of miR-7 was examined by
QPCR, and results are shown as mean  SEM of three individual experiments.
**P ≤ 0.01. EGFR, epidermal growth factor receptor.
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empty vector control (P ≤ 0.05). The MF was also increased (P ≤ 0.01),
but again not to the full extent of young fibroblasts (P ≤ 0.05 vs.
Fig. 2D). These data illustrate an alternative mechanism through which
miR-7 can regulate the differentiation response. The inhibition of HAS2
mRNA when overexpressing miR-7 in young fibroblasts (Fig. 4D) and the
restoration of HAS2 mRNA expression in aged fibroblasts transfected
with miR-7 LNA (Fig. 5C) suggest that there may be a HA-dependent
regulation of CD44 membrane motility that is operational in young but
not aged fibroblast cells.
Discussion
This report provides additional mechanisms and insights into the age-
associated loss of TGF-b1- dependent fibroblast to myofibroblast
differentiation. The importance of EGFR and its loss in cellular aging
has been described recently and been shown to have a significant effect
on the myofibroblast differentiation pathway (Meran et al., 2007;
Simpson et al., 2010; Meran & Steadman, 2011), going some way
towards explaining the mechanisms of resistance to TGF-b1-stimulated
differentiation (Shiraha et al., 2000; Simpson et al., 2010). In light of
these reports, we sought to determine the extent of the loss of EGFR in
our aged fibroblast cells and further detail the EGFR deficiency at
multiple levels including its transcriptional, translational, and cell surface
expression. Figure S1 further highlighted the importance of functional
EGFR signalling in the differentiation response. The data reported here
support previous findings of the age-associated loss of EGFR at the
mRNA and protein levels. However, the activity of the EGFR promoter
was not found to be significantly different between young and aged
fibroblasts. The maintenance of EGFR promoter activity indicated that
the transcription factors involved in EGFR transcription were unlikely to
be affected in an age- dependent manner and that there was another
factor responsible for the loss of EGFR mRNA, protein, and cell-surface
expression. We therefore hypothesized that age-associated loss of EGFR
could be regulated through the presence of mRNA inhibitors such as
miRNAs.
The results in this study also illustrated an age-associated loss of CD44
receptor membrane motility as demonstrated by FRAP confocal micros-
copy. The HA receptor CD44 can function as a co- receptor, physically
associating with several membrane-bound proteins, resulting in modu-
lation of intracellular signal transduction pathways and facilitating the
formation of specialized signalling complexes (Wang & Bourguignon,
2006a,b; Palyi-Krekk et al., 2008). The ability to do so with EGFR plays a
key role in myofibroblast differentiation (Midgley et al., 2013). While
CD44 was free to diffuse within the plasma membrane of young
fibroblasts, the ability of CD44 to diffuse freely was attenuated in aged
cells. As the loss of HA production by aged cells has also been described
previously (Simpson et al., 2009), we determined CD44 mobility to be
HA- dependent, and thus, a loss of overall HA could contribute to the
loss of CD44 cell membrane movement in aged fibroblasts. Figure S2
demonstrated that removal of HA production resulted in a loss of CD44
membrane motility.
Multiple reports have described miR-7 as having an important role in
the regulation of EGFR in cancer and development (Li & Carthew, 2005;
Kefas et al., 2008; Chou et al., 2010). However, this relationship
between miR-7 and EGFR has not been described in other areas of EGFR
function, such as fibroblast differentiation or age-associated loss of
(A)
(F) (G) (H)
(B) (C) (D) (E)
Fig. 4 Overexpression of miR-7 in young fibroblasts downregulates EGFR and inhibits differentiation. Young fibroblasts were grown to confluent monolayers and were
growth arrested for 24 h before transient transfection with either scrambled pre-miR or pre-miR-7. The relative expressions of (A) miR-7, (B) EGFR mRNA, (C) a-SMA mRNA,
(D) HAS2 mRNA, and (E) EDA-FN mRNA were examined by QPCR following incubation in serum-free medium alone or in medium containing 10 ng/mL TGF-b1 for 72 h.
Results shown are mean  SEM of three individual experiments. (F) Western blot analysis of total EGFR protein in young and aged fibroblasts. GAPDH was used as a loading
control. Representative blot is shown and densitometry results shown are the mean  SEM of three individual experiments. (G) Flow cytometry analysis of cell surface
expression of EGFR in young (green) and aged (red) fibroblasts. Unlabelled cells (black) were used as intensity controls. Bar graph of relative intensity is shown as the
mean  SEM of three individual experiments. (H) Cells were incubated in serum-free medium alone or in medium containing 10 ng/mL TGF-b1 for 72 h and then analysed
by immunocytochemistry for a-SMA. Representative images are shown for three individual experiments. *P ≤ 0.05, **P ≤ 0.01. EGFR, epidermal growth factor receptor.
EGFR, epidermal growth factor receptor; a-SMA, a-smooth muscle actin.
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phenotype. In silico analysis identified the highly reflect the downreg-
ulated EGFR mRNA present in aged fibroblasts. Additionally, an
interesting observation was made in the young fibroblast group,
wherein miR-7 was upregulated and EGFR mRNA downregulated in
response to TGF-b1. Whether this change to miR-7 and in turn EGFR
mRNA is directly modulated by TGF-b1 stimulation is not currently
known and requires further investigation; however, a possible mecha-
nism of miR-7 activity has been shown through its promotion by EGFR
signalling and c-Myc (Chou et al., 2010).
Interestingly, through miR-7 overexpression in young fibroblasts, we
were able to mimic the decreased expression of EGFR observed in aged
fibroblasts, further supporting a role for miR-7 in age-associated
regulation of EGFR and the differentiation response. Furthermore, the
inhibition of miR-7 in aged fibroblasts significantly induced EGFR mRNA,
protein, and cell-surface expression, together with HAS2 mRNA.
Additionally, in response to TGF-b1 treatment in the presence of miR-
7 inhibition, there was successful upregulation of a-SMA fibril formation
and induction of a-SMA, HAS2, and EDA-FN mRNA, indicating restored
differentiation of fibroblasts to myofibroblasts. The importance of
HA-CD44 in mediating differentiation (Sherman et al., 1994; Bourgui-
gnon et al., 2006) and the TGF-b1-induced myofibroblast response
(Meran et al., 2007; Simpson et al., 2009, 2010; Webber et al., 2009;
Meran & Steadman, 2011) has been previously documented. We were
interested in examining CD44 in the cellular membrane of young and
aged cells in response to miR-7 overexpression and inhibition, respec-
tively. Overexpression of miR-7 in young cells resulted in diffusion rates
of CD44 declining to similar levels as those found in aged fibroblasts. In
addition, the inhibition of miR-7 in aged fibroblasts restored the diffusion
rates of CD44 to levels observable in young fibroblasts. As inhibition of
miR-7 with LNA was able to upregulate both EGFR and HAS2 mRNA, we
tested the hypothesis that overexpression of either in aged fibroblasts
could restore CD44 movement. Although overexpression of EGFR had
no effect on CD44 motility (data not shown), HAS2 overexpression did
restore CD44 movement to rates observable in young fibroblasts and
aged fibroblasts transfected with miR-7 LNA. Therefore, we propose that
HAS2 synthesis of HA is an important mechanism-mediating CD44
lateral movement throughout the cellular membrane and that miR-7 can
regulate HAS2 expression through the inhibition of EGFR and compo-
nents of its signalling pathway, therefore indirectly affecting CD44
movement in order to prevent cellular differentiation. Indeed, miR-7 has
been shown to inhibit the Akt/mTOR pathway downstream of EGFR
signalling (Kefas et al., 2008; Webster et al., 2009), and an association
between Akt and HAS2 production has previously been illustrated (Kultti
et al., 2010; Bernert et al., 2011).
Explanation of how miR-7 inhibition could rescue age-associated loss
of differentiation while EGFR overexpression alone could not (Simpson
et al., 2010) may be a result of the mRNA targets of miR-7. In silico
analysis of miR-7 seed sites revealed potential targets on neither HAS2,
a-SMA nor CD44. However, there were several targets of miR-7 within
the EGFR-signalling pathway, the activation of these are necessary for
HAS2 induction, the reorganization of the actin cytoskeleton, a- SMA
upregulation and myofibroblast differentiation. These targets included
MAPK/ERK, CaMKII, Rho-GTPase, PI3K, Akt and mTOR. EGFR overex-
pression in aged fibroblasts (Simpson et al., 2010) failed to successfully
(A)
(E) (F) (G)
(B) (C) (D)
Fig. 5 Inhibition of miR-7 with LNA rescues age-associated loss of differentiation. Aged fibroblasts were grown to confluent monolayers and were growth arrested for 24 h
before transient transfection with either negative control LNA or miR-7 LNA. The relative expressions of (A) EGFR mRNA, (B) a-SMA mRNA, (C) HAS2 mRNA, and (D) EDA-FN
mRNA were examined by QPCR following incubation in serum-free medium alone or in medium containing 10 ng/mL TGF-b1 for 72 h. Results shown are the mean  SEM
of three individual experiments. (E). Western blot analysis of total EGFR protein in young and aged fibroblasts. GAPDH was used as a loading control. Representative blot is
shown and densitometry graph shown is mean  SEM of three individual experiments. (F) Flow cytometry analysis of cell surface expression of EGFR in young (green) and
aged (red) fibroblasts. Unlabelled cells (black) were used as intensity controls. Bar graph of relative intensity shown is mean  SEM of three individual experiments. (G) Cells
were incubated in serum-free medium alone or in medium containing 10 ng/mL TGF-b1 for 72 h and then analysed by immunocytochemistry for a-SMA. Representative
images are shown for three individual experiments. *P ≤ 0.05, **P ≤ 0.01. . EGFR, epidermal growth factor receptor. EGFR, epidermal growth factor receptor; a-SMA, a-
smooth muscle actin; LNA, locked nucleic acids.
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restore differentiation; it is possible that this was due to an elevated
expression of miR-7 in aged cells, not only inhibiting EGFR mRNA but
also the production of its downstream targets and thus HAS2 and
a-SMA gene induction. Bypassing the EGFR pathway and also overex-
pressing HAS2 could restore differentiation, and this is likely through the
increased production of HA, restoration of CD44 membrane motility and
its interaction with EGFR, solidifying the signalling response of EGFR and
providing sufficient activity to trigger the differentiation response in aged
fibroblasts.
We propose a mechanism through which miR-7 upregulation in aged
cells is able to downregulate EGFR protein and expression through
targeting EGFR mRNA for breakdown and has additional targets within
the EGFR-dependent signalling pathway that directly regulate HAS2
production. The consequence of miR-7 activity therefore results in the
downregulation of the key cellular components; EGFR and HAS2,
involved in fibroblast to myofibroblast differentiation. Additionally, as a
direct result of reduced HAS2 expression, there is a reduction in HA
production and binding to CD44, compromising its ability to move
(B)(A)
(D)(C)
(F)(E)
Fig. 6 Young fibroblasts overexpressing miR-7 lose CD44 motility, aged fibroblasts transfected with miR-7 inhibitor restore CD44 motility in a similar manner to HAS2
overexpression. Young or aged fibroblasts were grown to 70% confluent monolayers on 22-mm-diameter glass coverslips in 35-mm six-well tissue culture plates. Cells were
growth arrested in serum-free medium for 48 h. FRAP was performed at 37 °C by photobleaching an approximately 10 lm area of the cell membrane. The recovery of
fluorescence into this area was quantified and expressed as a fraction of the fluorescence intensity (FI) of a second region of membrane outside of the photobleached area (FI
Ratio). Complete quantified time-courses, average diffusion constants (D) and mobile fractions (MF) are shown for CD44 in: young cells transfected with (A) scrambled pre-
miR or (B) pre-miR-7, and aged cells transfected with (C) negative control LNA, (D) miR-7 LNA, (E) empty pCR3.1 vector, or (F) pCR3.1-HAS2 overexpression vector. All results
shown are mean  SEM of five independent experiments. LNA, locked nucleic acids.
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throughout the cellular membrane and thus a reduction in its interaction
with EGFR in response to TGF-b1 (Wang & Bourguignon, 2006b;
Simpson et al., 2010; Meran et al., 2011), an essential step in driving
differentiation.
The loss of cellular phenotype and response to stimulation is a pivotal
change in cellular aging. Age-related loss of fibroblast-to-myofibroblast
differentiation is often associated with failure of normal wound healing
and contraction leading to chronic nonhealing wounds in the elderly.
Chronic nonhealing wounds have been estimated to affect 4% of the
UK population over the age of 65, and the morbidity associated with this
impaired wound healing is estimated to cost the health service in excess
of £1 billion annually in the United Kingdom (Ashcroft et al., 2002) and
$9 billion in the United States (Ashcroft & Roberts, 2000). With the costs
rising in correlation with the aging population’s ever-increasing life
spans; chronic wounds pose a real problem to present and future
healthcare across the world. In this study, we report a novel insight into
the targeting of miR-7 in aged fibroblasts, to rescue and promote
differentiation into myofibroblasts and therefore drive effective wound
healing in the elderly.
Experimental procedures
Materials
All reagents were from Sigma-Aldrich (Poole, UK) unless otherwise
stated. The primary antibodies and dilutions used for western blot
analysis, immunocytochemistry, flow cytometry and confocal microscopy
were monoclonal mouse anti-EGFR (1:1000) from Calbiochem (Darms-
tadt, Germany), monoclonal mouse anti-a-SMA (1:50) from DAKO
(Aachen, Germany), monoclonal mouse anti-EGFR-FITC (1:1000) and
monoclonal rat anti-CD44-FITC (1:1000) from Abcam (Cambridge, UK),
respectively. Reverse transcription, pre-miR-7 and pre-miR-Scramble
transfection reagents, and QPCR primers and reagents were purchased
from Invitrogen and Applied Biosystems (Cheshire, UK). Other reagents
used were recombinant TGF-b1 from R&D Systems (Abingdon, UK), and
miR-7 and negative control miR miRCURY LNA from Exiqon (Denmark,
EU).
Cell culture
Primary human lung fibroblasts (AG02262; NIA Aging Cell Respiratory
Corriel Institute, Camden, NJ, USA) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) and F-12 medium containing 2 mM L-glutamine,
100 units/mL penicillin, and 100 lg/mL streptomycin supplemented with
10% foetal calf serum (FCS; Biologic Industries Ltd., Cumbernauld, UK).
The cells were maintained at 37 °C in a humidified incubator in an
atmosphere of 5%CO2, and fresh growthmediumwas added to the cells
every 3–4 days until confluence. Cells were growth arrested in serum-free
medium for 48 h before use in experiments, and all experiments were
performed under serum-free conditions unless otherwise stated. All
experiments involving young fibroblasts used cells at passages 6–8
[population doubling level (PDL) 15–20]; while those involving aged
fibroblasts used cells at presenescent late passages 14–15 (PDL 25–28);
cells underwent senescence at PDL 30 as determined by growth curves
(data not shown). All experiments were performed on confluent cultures
except for those experiments using antibody visualization, subconfluent
cells of approximately 70% confluence were used for optimal antibody
coverage. Myofibroblasts were differentiated by the incubation of
fibroblast cultures in serum-free medium containing 10 ng/mL TGF-b1
for 72 h.
Reverse transcription (RT) and real-time quantitative
polymerase chain reaction (RT-QPCR)
RT and QPCR-RT were used to assess EGFR, a-SMA, HAS2 and EDA-FN
mRNA expression in fibroblasts or myofibroblasts. The cells were grown
in 35-mm dishes and washed with PBS prior to transcription was
performed using the high-capacity cDNA reverse transcription kits
according to the manufacturer’s protocol (Applied Biosystems, Cheshire,
UK). This uses the random primer method for initiating cDNA synthesis.
As a negative control, RT was performed with sterile H2O replacing the
RNA sample. QPCR was performed as in our previous studies (Simpson
et al., 2010) using the 7900HT Fast Real-Time PCR System (Applied
Biosystems). Ribosomal RNA (rRNA) was used as an endogenous control.
MicroRNA-RT and QPCR were performed for miR-7 according to
TaqMan MicroRNA Assays (Applied Biosystems) and miR-16 was used
as an endogenous control.
Western blot analysis
Western blot analysis was used to assess expression of total EGFR. Cells
were grown to confluence in 35-mm dishes; total protein was extracted
in RIPA lysis buffer containing 1% PIC, 1% PMSF and 1% SO (Santa Cruz
Biotechnology, CA, USA). Western blot analysis was carried out as
described in our previous work (Simpson et al., 2010). The nitrocellulose
membranes were incubated with the appropriate primary antibodies in
1% BSA, 0.1% Tween-PBS. Expression of GAPDH was analysed as a
control to ensure equal loading (rabbit anti-GAPDH; 1:5000 dilution).
The secondary antibodies used were anti-mouse IgG/horseradish perox-
idize conjugate (Abcam, Cambridge, UK; 1:5000 dilution in 1% BSA,
0.1% Tween-PBS), and anti-rabbit IgG/horseradish peroxidize conjugate
(Cell Signalling Technology, Beverly, MA; 1:5000 dilution in 1% BSA,
0.1% Tween-PBS). Detection was performed using ECL reagent (GE
Healthcare, Amersham, UK).
Flow cytometry
Young and aged fibroblasts were grown to confluence and growth
arrested in serum-free medium for 48 h. Cells were washed with PBS
and incubated with 0.01% trypsin-EDTA to lift the cells. Trypsin was
subsequently neutralized with FCS, and the cell solution was centrifuged
at 1500 g for 5 min at 20 °C. The supernatant was aspirated and the
cell pellet resuspended in 1% BSA-PBS containing the primary fluoro-
phore-conjugated antibody for 30 min on ice, before washes and
resuspension in 1% BSA-PBS. Flow cytometry was performed using a
FACSCanto II flow cytometer (BD Biosciences), and data were analysed
using FlowJo version 7 (Tree Star, Ashland, OR, USA).
Luciferase reporter plasmid generation
A 200 bp insert encoding the EGFR promoter was PCR amplified using
the Phusion DNA polymerase system (New England Biolabs, Herts, UK)
from the forward primer; 5′-ACTCCCGCCGGAGACTAGGT-3′ and the
reverse primer; 5′- CCGCGTCGGGCGCTCACACC-3′ with the addition
of KpnI and XhoI endonuclease restriction sites, respectively. Amplified
promoter inserts were PCR purified, digested with the appropriate
endonuclease restriction enzymes (New England Biolabs) for 2 h at
37 °C, electrophoresed and extracted from 1% agarose gel according to
Qiagen gel extraction kit protocol (Qiagen, Barcelona, Spain). Inserts
were then ligated together with KpnI and XhoI digested pGL3Basic
(pGL3b) vector using the T4 DNA ligase system (New England Biolabs)
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overnight at 16 °C. The pGL3b plasmid containing the 200 bp EGFR
promoter insert (pGL3b-EGFR) was then transformed using the 42 °C
heat-shock method into one-shot competent Escherichia coli (New
England Biolabs) and grown overnight on ampicillin containing agar.
Single colonies were extracted, cloned and DNA purified according to
the Miniprep Kit protocol (Sigma-Aldrich). Cloned pGL3b-EGFR vector
uptake of insert was confirmed with DNA sequencing.
HAS2-overexpression vector generation
TheHAS2open-reading frame (Simpson et al., 2009)was inserted into the
vector pCR3.1 using a standard ligation reaction with T4 DNA ligase (New
England Biolabs). Amplification of the cloned vector was performed via
bacterial transformation into one-shot competent Escherichia coli (New
England Biolabs) and grown overnight on ampicillin containing agar.
Single colonies were extracted, cloned and DNA purified according to the
Miniprep Kit protocol (Sigma-Aldrich). Cloned pCR3.1-HAS2 vector
uptake of insert was confirmed with DNA sequencing. Negative RT
experiments were performed alongside HAS2mRNA QPCR to ensure that
the pCR-3.1-HAS2 was not conveying false-positive overexpression.
Transfection
Plasmid pGL3b-EGFR, pCR3.1-HAS2 and miRCURY LNA transfections
were completed using the Lipofectamine LTX system (Invitrogen, Paisley,
UK) according to protocol following optimization of transfection. Pre-
miR-7 transfectionswere completed using the Lipofectamine 2000 system
(Invitrogen) according to theprotocol followingoptimization. Transfection
optimization and efficiency was determined by co-transfection of GFPmax
vector (Amaxa, Cologne, Germany). Cells were incubated for 24 h
following transfection prior to continuation of experiments.
Luciferase reporter analysis
Reporter analysis was performed 24 h after transfection using the Dual-
Luciferase reporter assay kit (Promega, Southampton, UK) and detected
with a FLUOstar OPTIMA plate reader (BMG Labtech, UK). Renilla
luciferase was co-transfected with pGL3b-EGFR and used as a control for
transfection efficiency and for normalization of data.
Immunocytochemistry
Cells were grown to 70% confluence in eight-well glass chamber slides.
The culture medium was removed, and the cells were washed with
sterile PBS prior to fixation in 4% paraformaldehyde for 10 min at room
temperature. To ensure visualization of cytoskeletal proteins, fixed slides
were permeabilized with 0.1% Triton X-100 in PBS for 10 min when
necessary. Slides were washed with PBS and then blocked with 1% BSA
for 30 min prior to a further washing step. Subsequently, the slides were
incubated with the primary antibody diluted in 0.1% BSA/PBS overnight
at 4 °C. Following a further wash step, slides were incubated with
secondary antibodies for 1 h at room temperature in darkness (anti-
mouse IgG/AlexaFluor 488; Invitrogen). Cells were then mounted and
analysed by fluorescent microscopy.
Laser confocal microscopy and fluorescence recovery after
photobleaching
Cells were grown to 70% confluence on 22-mm-diameter glass coverslips
in 35-mm dishes. Following appropriate experimental methods, the
coverslip was removed from the medium and mounted on a heated
microscope stageat 37 °C. Five hundredmicrolitres ofmediumwasplaced
onto the mounted coverslip and the primary fluorophore-conjugated
antibodywas added.Analysiswas performedby laser confocalmicroscopy
and FRAP.
Leica Confocal Software (Leica Microsystems, Hamburg GmbH) was
used to assess FRAP data and generate fluorescence intensity ratios
(FI ratio); defined as FI ratio = Fz/Fo, Where Fz is the intensity of the
photobleached zone, and Fo is the intensity of the control region taken
from outside of the photobleached zone. Average diffusion constants
(D) were calculated from the D = (w2/2t½)cD equation Where w is the
radius of the photobleached area, t½ is the half time of fluorescent
recovery and cD is a constant that is dependent on experimental
conditions (Axelrod et al., 1976). Mobile fractions (MF) represent the
fraction of receptors that had the ability to recover into the photo-
bleached zone over the observed time.
Statistical analysis
Western blot images were densitometrically analysed by ImageJ (NIH
Software, Bethesda, MD, USA). Graphical data are expressed as
means  SEM. The unpaired two-tailed Student’s t-test was used to
identify statistical significance. Data were analysed using the software
MiniTab version 15.0 (Minitab Solutions, State College, PA, USA), and
*P ≤ 0.05; **P ≤ 0.01 was considered significant.
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Fig S1. Inhibition of EGFR prevented upregulation of key differentiation
components by TGF-b1.
Fig S2. Inhibition of HA synthesis resulted in loss of CD44 membrane
motility.
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